Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Fabio Dardi"'
Autor:
Fabio Dardi, Daniele Guarino, Alberto Ballerini, Riccardo Bertozzi, Federico Donato, Francesco Cennerazzo, Monica Salvi, Elena Nardi, Ilenia Magnani, Alessandra Manes, Nazzareno Galiè, Massimiliano Palazzini
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Background Haemodynamic variables like right atrial pressure (RAP), cardiac index (CI), stroke volume index (SVI) and mixed venous oxygen saturation (SvO2) predict survival in patients with pulmonary arterial hypertension (PAH). However, there is the
Externí odkaz:
https://doaj.org/article/b47e618ade2642f9a0e06cc52d46b105
Autor:
Elena Nardi, Nazzareno Galiè, Fabio Dardi, Alessandra Manes, Daniele Guarino, Elisa Zuffa, Alessandro De Lorenzis, Ilenia Magnani, Mariangela Rotunno, Alberto Ballerini, Gerardo Vito Lo Russo, Massimiliano Palazzini
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Objective To optimise treatment of patients with pulmonary arterial hypertension (PAH), the 2015 European Society of Cardiology/European Respiratory Society guidelines recommend using risk stratification, with the aim of patients achieving low-risk s
Externí odkaz:
https://doaj.org/article/6e609dc938ea4ccdac1807e19b047e57
Autor:
Massimiliano Palazzini, Fabio Dardi, Ilenia Magnani, Daniele Guarino, Nazzareno Galie’, Alessandra Manes
Publikováno v:
European Heart Journal Supplements. 25:B90-B94
The combination of an initial clinical approach aimed at evaluating the early risk of mortality with subsequent diagnostic and therapeutic approaches articulated on the overall patient’s profile is recommended in acute pulmonary embolism (PE). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e42a99f05e6a96f08d740569e700637e
https://doi.org/10.1093/eurheartjsupp/suad080
https://doi.org/10.1093/eurheartjsupp/suad080
Autor:
Fabio Dardi, Federico Donato, Daniele Guarino, Ilenia Magnani, Riccardo Bertozzi, Mariangela Rotunno, Alberto Ballerini, Giulia Martini, Alessandra Manes, Massimiliano Palazzini, Nazzareno Galiè
Publikováno v:
European Heart Journal Supplements. 24
Background Pulmonary arterial hypertension (PAH) represents a rare complication of both portal hypertension (Po-PAH) and HIV infection (HIV-PAH). Due to overlapping risk factors, in the latter patients there may frequently be a hepatic involvement th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d9d4ee47da968e7e05fa3638d57dde4
https://doi.org/10.1093/eurheartjsupp/suac121.258
https://doi.org/10.1093/eurheartjsupp/suac121.258
Autor:
Ilenia Magnani, Alessandra Manes, Giampiero Dolci, Elena Salvaterra, Niccolò Daddi, Gian Maria Paganelli, Filippo Antonacci, Daniele Guarino, Fabio Dardi, Massimiliano Palazzini, Nazzareno Galiè
Publikováno v:
European Heart Journal Supplements. 24
Background despite the approval of pulmonary arterial hypertension (PAH) specific therapies, bilateral lung transplantation (LT) remains the therapeutic option of choice for patients that fail to reach an adequate clinical and hemodynamic response on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a57cffe4726e67207af05c026684b22
https://doi.org/10.1093/eurheartjsupp/suac121.261
https://doi.org/10.1093/eurheartjsupp/suac121.261
Autor:
Ilenia Magnani, Alessandra Manes, Fabio Dardi, Emanuela Concetta D´angelo, Daniele Guarino, Alberto Ballerini, Mariangela Rotunno, Federico Donato, Riccardo Bertozzi, Giulia Martini, Massimiliano Palazzini, Andrea Donti, Nazzareno Galiè
Publikováno v:
European Heart Journal Supplements. 24
Background patients with pulmonary arterial hypertension (PAH) associated with corrected congenital heart disease (CHD) have a worse prognosis than other 3 groups of patients with PAH associated with CHD (Eisenmenger, small defect, prevalent systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3ca85aeff87534b8bc908051d232d77
https://doi.org/10.1093/eurheartjsupp/suac121.260
https://doi.org/10.1093/eurheartjsupp/suac121.260
Autor:
Fabio Dardi, Riccardo Bertozzi, Daniele Guarino, Ilenia Magnani, Mariangela Rotunno, Alberto Ballerini, Federico Donato, Giulia Martini, Alessandra Manes, Massimiliano Palazzini, Nazzareno Galiè
Publikováno v:
European Heart Journal Supplements. 24
Background despite therapeutic improvement, pulmonary arterial hypertension (PAH) is still a chronic, incurable, high mortality disease. Several clinical, laboratory, hemodynamic and instrumental prognostic factors have been already established in PA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d968742ce3ccfd59d05ee399da4753f
https://doi.org/10.1093/eurheartjsupp/suac121.262
https://doi.org/10.1093/eurheartjsupp/suac121.262
Autor:
Fabio Dardi, Giulia Martini, Daniele Guarino, Ilenia Magnani, Mariangela Rotunno, Alberto Ballerini, Riccardo Bertozzi, Federico Donato, Alessandra Manes, Massimiliano Palazzini, Nazzareno Galiè
Publikováno v:
European Heart Journal Supplements. 24
Background Pulmonary arterial hypertension (PAH) is a progressive disease characterized by small pulmonary arteries remodeling that leads to increased pulmonary vascular resistance, dyspnea, fatigue, right heart failure and ultimately death. Prostacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17dca267d690dec15e1b2e7c14918459
https://doi.org/10.1093/eurheartjsupp/suac121.259
https://doi.org/10.1093/eurheartjsupp/suac121.259
Autor:
Fabio Dardi, Daniele Guarino, Francesco Cennerazzo, Alberto Ballerini, Ilenia Magnani, Riccardo Bertozzi, Federico Donato, Giulia Martini, Alessandra Manes, Nazzareno Galiè, Massimiliano Palazzini
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 10; Pages: 3425
Background: Pulmonary arterial hypertension (PAH) may complicate both portal hypertension (Po-PAH) and HIV infection (HIV-PAH). These two conditions, however, frequently coexist in the same patient (HIV/Po-PAH). We evaluated clinical, functional, hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93aff7ccbe911571aac7a3245bcb368c
https://doi.org/10.3390/jcm12103425
https://doi.org/10.3390/jcm12103425
Autor:
Sofia Martin-Suarez, Gregorio Gliozzi, Giulio Giovanni Cavalli, Valentina Orioli, Antonio Loforte, Saverio Pastore, Barbara Rossi, Davide Zardin, Nazzareno Galiè, Massimiliano Palazzini, Fabio Dardi, Francesco Saia, Fabio Niro, Davide Pacini
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 15; Pages: 4353
Background: Pulmonary endarterectomy (PEA) is the gold standard therapy for chronic thromboembolic pulmonary hypertension (CTEPH). Traditionally, pulmonary vascular resistance (PVR) represents the main prognostic factor after surgery. The pulmonary a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80c5631b1a3b595d2c1e66a8927a4cb
https://pubmed.ncbi.nlm.nih.gov/35955972
https://pubmed.ncbi.nlm.nih.gov/35955972